E-MED: (2)A propos de la phenylpropanolamine
---------------------------------------------------------------------
La Phenylpropanolamine (PPA) est un decongestant sympathomimetique
systemique qui etait l'un des principes actifs de nombreuses preparations
utilisees pour le traitement symptomatique des congestions ou obstructions
nasales. En Novembre 2000, l'agence chargee des Medicaments aux Etats-Unis
la Food and Drug Administration (FDA) attirait l'attention du public sur les
riques considerable associes a la prise de la Phenylpropanolamine, en
particulier, trouble cardiovasculaires (hemorrhagic stroke) et musculaires
(rhabdomyolysis). La FDA avait base sa decision sur les resultats d'une
recherche intitulee The Hemorrhagic Stroke Project (HSP) et avait donc
recommande que les laboratoires fabricants arretent de facon volontaire la
promotion et la distribution de tous les produits de conseil (OTC) et sur
ordonnance contenant ce principe actif. Ainsi, tous les produits conteant la
PPA avaient ete retires du marche Americain et Canadien en novembre 2000,
beaucoup d'entre eux ont ete par la suite reformules et re-introduits sur le
marche pharmaceuttique Americain. Pour plus de renseignements sur ce sujet,
se referer a l'article (en Anglais): "Phenylpropanolamine and Hemorrhagic
Stroke." Ernst ME & Hartz A. New England Journal of Medecine 2001, April
5;344:1094, disponible sur Medline ou sur souscription sur le site du
Journal www.nejm.com.
"OUSMANE T. SECK"
ousmanethiane@yahoo.com
Dear All,
While the scholarship scheme for the Global Health Workforce Alliance (GHWA) Forum in Kampala, Uganda, in March 2008 is still being finalized, it appears very likely that if you have an abstract approved you will have a better chance, possibly a much better chance, of receiving GHWA financial support than if you do not submit an abstract (and have it approved). Therefore, if you will need financial support and might be able to submit an abstract, I strongly encourage you to go ahead and submit an abstract. For details, please see the call for papers at
http://www.who.int/entity/workforcealliance/forum/GHWA_Forum_Call_For_Papers/en/index.html (deadline December 31). Also please register:
http://www.who.int/entity/workforcealliance/forum/GHWA_Forum_Registration/en/index.html (deadline January 31, 2008).
The Health Workforce Advocacy Initiative is advocating for a strong NGO and health worker presence at the Forum. In that context, please email me if you would like to attend the Forum and will require financial support to do so. Please email me your name, affiliation/position, and country, and please do so as soon as possible. Please also let me know if you are submitting an abstract. Knowing who among civil society would like to attend the Forum will enhance our ability to advocate for funding through GHWA for you and others health workers and civil society participants.
Please note that we can make no guarantees about GHWA funding -- depending on demand, it is quite possible that the number of people who would require funding will exceed the resources available through GHWA for financial support. Therefore, if you have alternative possible funding sources, I encourage you to pursue them.
As before, I encourage you to reach out to colleagues who might be interested in attending the Forum.
Please take care to just email me (mailto:efriedman@phrusa.org), and do not reply to the entire listserv.
Thank you.
Peace,
Eric
Eric A. Friedman
Senior Global Health Policy Advisor
Physicians for Human Rights
1156 15th Street, NW, Suite 1001
Washington, DC 20005 USA
Phone: +1-202-728-5335 ext. 303
Fax: +1-202-728-3053
E-mail: mailto:efriedman@phrusa.org
Website: http://www.physiciansforhumanrights.org